72V-14667-55575 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-05
Dose 1 — Pfizer-BioNTech
2021-01-26
Dose 2 — Pfizer-BioNTech
2021-01-28
Registered in v-safe
2021-01-28
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Swollen lymph nodes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-28
Report sent to call center — days 1–6 daily, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-29
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling

Free text: Swollen lymph nodes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-10
Call 1 — Left Voicemail
2021-10-03
Dose 3 — Pfizer-BioNTech

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-05	Pfizer-BioNTech
2	2021-01-26	Pfizer-BioNTech
3	2021-10-03	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-01-28	Unsuccessful

Free text

Release 2 — days 1–6 daily, dose 2

2021-01-28

Systemic reaction (other): Swollen lymph nodes

Release 3 — days 1–6 daily, dose 2

2021-01-29

Systemic reaction (other): Swollen lymph nodes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release